The biotechnology company will debut its first product at the in-cosmetics Global trade show from March 28-30, in Barcelona
BERLIN, March 23, 2023 (GLOBE NEWSWIRE) — Biotechnology company Cambrium has launched its first product: NovaColl. It is the first micro-molecular & 100% skin-identical collagen specifically designed for premium personal care formulations.
Owing to its structure and small molecular size, NovaColl is able to create powerful collagen benefits across skin layers. This new class of collagen active is vegan certified and produced through Cambrium’s precision fermentation process, offering formulators a unique combination of efficacy, skin-compatibility and sustainability.
NovaColl’s claims have been scientifically validated in third party in vitro studies, which demonstrated a broad range of activities working to holistically protect, maintain and enhance native collagen.
Beyond bio-similarity, NovaColl is 100% skin-identical, offering previously inaccessible levels of biocompatibility for personal care applications. To achieve this, Cambrium’s multi-disciplinary team of scientists and engineers searched through billions of protein sequences for skin-active features and indicators of efficacy. They identified NovaColl, a highly bioactive region of collagen I, the most prevalent collagen type in our human skin.
Rather than extracting collagen from animals, Cambrium uses yeast cells to grow their micro-molecular collagen in a cruelty-free and sustainable fermentation process, minimizing energy, land, and water use.
Cambrium will exhibit at booth AK84 at the in-cosmetics Global trade show from March 28-30 in Barcelona, Spain. For more information about NovaColl and to request a meeting, please write to email@example.com.
Cambrium’s mission is to trigger the next wave of sustainable product innovation through the creation of new, high performance molecules. Using their technology-enabled molecular design platform, they discover, develop and manufacture proteins that unlock previously inaccessible functionalities. For more information, visit www.cambrium.bio.
A photo accompanying this announcement is available at https://www.globenewswire.com/
GlobeNewswire Distribution ID 8793925